MDST:NYE-Ultimus Managers Trust (USD)

ETF | Others |

Last Closing

USD 27.13

Change

-0.14 (-0.52)%

Market Cap

USD 0.07B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.23 (-1.23%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.40 (-0.68%)

USD 37.61B
DFAC Dimensional U.S. Core Equity 2..

-0.34 (-0.96%)

USD 33.40B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 28.50B
JPST JPMorgan Ultra-Short Income ET..

+0.03 (+0.06%)

USD 28.13B
DTB DTE Energy Company 2020 Series

-0.35 (-1.89%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-0.88 (-1.16%)

USD 21.47B
JAAA Janus Detroit Street Trust - J..

+0.04 (+0.08%)

USD 16.06B
AVUV Avantis® U.S. Small Cap Value..

-1.13 (-1.16%)

USD 15.95B
DFUS Dimensional U.S. Equity ETF

-0.71 (-1.08%)

USD 13.15B

ETFs Containing MDST

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.07B 53% F 23% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike